Prolong Pharma to Present Data from HEMERA-1 for PP-007 in AIS
05 Feb 2025 //
BUSINESSWIRE
Prolong Pharma to Present PP-007 Data at Blood Substitutes Symposium
13 Nov 2024 //
BUSINESSWIRE
FDA Grants Prolong Fast Track Designation for Stroke Therapy
30 Oct 2024 //
BUSINESSWIRE